Cannabis-based Epidiolex reduces seizures by as much as 50%, according to study
The cannabis product was the first to receive FDA approval, and has shown significant health benefits Dravet (DS) and Lennox-Gastaut (LGS) syndromes are two severe, treatment-refractory, pediatric-onset epileptic syndromes associated